新闻 创伤后应激障碍 退伍军人

克里雅2016–氯胺酮研究所年会

通过 2016年12月5日 没意见
[imageframe lightbox =”no” gallery_id=”” lightbox_image=”” style_type=”dropshadow” hover_type=”zoomin” bordercolor=”” bordersize=”0px” borderradius=”0″ stylecolor=”” align=”center” link=”” linktarget=”_self” animation_type=”0″animation_direction =”down” animation_speed=”0.1″ animation_offset=”” hide_on_mobile=”no” class=”” id=””] Bonnett博士出席2016年KRIYA会议[/ imageframe] [分隔符style_type =”single” top_margin=”10px” bottom_margin=”10px” sep_color=”” border_size=”” icon=”” icon_circle=”” icon_circle_color=”” width=”” alignment=”center” class=”” id=””] [fusion_text]这个周末,我有幸参加了KRIYA氯胺酮研究所年度会议(kriyainstitute.com)。这是与世界各地的氯胺酮研究人员和临床医生会面的绝佳机会。我们能够比较笔记,回顾与氯胺酮有关的最新研究,并讨论有关使用氯胺酮治疗抑郁症,创伤后应激障碍(PTSD),其他精神健康状况和慢性疼痛的最佳实践。和往常一样,博士特里·厄里(Terry Early)和菲尔·沃尔夫森(Phil Wolfson)就氯胺酮辅助的便利心理治疗的使用进行了精彩的演讲。值得注意的是,人们对氯胺酮在医学中的重要性的认识正在迅速增长。詹妮弗·怀恩加登(Jennifer Winegarden)博士特别演讲了关于氯胺酮在临终关怀医学和临终关怀中的使用的演讲。讨论的经常要点之一是麻醉性止痛药可能是危险的并且适得其反。氯胺酮疗法确实会真正改变如何控制慢性疼痛的整个范式。[/ fusion_text] [title size =”2″ content_align=”left” style_type=”default” sep_color=”” margin_top=”” margin_bottom=”” class=”” id=””]氯胺酮趋势[/ title] [fusion_text]博士,一如既往。特里·厄里(Terry Early)和菲尔·沃尔夫森(Phil Wolfson)就氯胺酮辅助的便利心理治疗的使用进行了精彩的演讲。值得注意的是,人们对氯胺酮在医学中的重要性的认识正在迅速增长。詹妮弗·怀恩加登(Jennifer Winegarden)博士特别演讲了关于氯胺酮在临终关怀医学和临终关怀中的使用的演讲。讨论的经常要点之一是麻醉性止痛药可能是危险的并且适得其反。氯胺酮疗法确实会真正改变如何控制慢性疼痛的整个范式。[/ fusion_text] [title size =”2″ content_align=”left” style_type=”default” sep_color=”” margin_top=”” margin_bottom=”” class=”” id=””氯胺酮的迷幻作用?[/ title] [fusion_text]另一个有趣的话题是氯胺酮的拟精神病(“迷幻药”)作用是不良反应还是治疗的一部分。我与之交谈的大多数临床医生都同意我的看法,即氯胺酮输注过程中患者经历的“脱节”感觉和感觉的轻度改变非常有治疗意义,实际上是治疗的重要组成部分。我们在克拉丽萨娜(Klarisana)将此现象称为“精神治疗反应”或“ PTR”。显然,发生了涉及NMDR受体的复杂的生化反应,但作用机理远不止于此。除了氯胺酮在生化水平上的作用更加复杂之外,我相信氯胺酮输注的体验质量对于成功至关重要。这是我们将在即将进行的PTSD研究中开始处理的一个要素,但也将在今年晚些时候的研究中尝试进行更仔细的研究。[/ fusion_text] [title size =”2″ content_align=”left” style_type=”default” sep_color=”” margin_top=”” margin_bottom=”” class=”” id=””海洛因成瘾者的氯胺酮疗法[/ title] [fusion_text]

Another lecture which was fascinating was by Dr. Evgeny Krupitsky from St. Petersburg, Russia. He presented the results of a couple of his studies looking at ketamine therapy in patients with heroin addiction. He has been able to show a decrease level of relapse in heroin users after ketamine therapy. In many of our patients with chronic pain who respond to ketamine therapy we note a dramatic decrease in the reliance on narcotic pain medication (hydrocodone, oxycodone, etc.). I think this observation has profound implications for patients with chronic pain and for society at large. Given the prescription narcotic abuse epidemic and the heroin epidemic in this country I hope that academic 中央s will aggressively study the role that ketamine could play in chronic pain management.[/fusion_text][title size=”2″ content_align=”left” style_type=”default” sep_color=”” margin_top=”” margin_bottom=”” class=”” id=””]资深案例研究[/ title] [fusion_text]

最后,在会议的第二天,我介绍了一个案例系列,其中有五名患有严重创伤后应激障碍的退伍军人。氯胺酮治疗后,所有患者的症状和生活质量均有显着改善。我们就美国退伍军人在精神卫生服务和基本医疗保健方面面临的挑战进行了非常愉快的讨论。[/ fusion_text] [title size =”2″ content_align=”left” style_type=”default” sep_color=”” margin_top=”” margin_bottom=”” class=”” id=””]What’s Next?[/title][fusion_text]I 剩下 the conference feeling more energized to raise awareness among lawmakers as to how ketamine can positively improve the veteran suicide rate and the rates of domestic violence in families who have a veteran with 创伤后应激障碍 . At the same time, it does make me frustrated to think about how many more veterans and non-veterans alike will complete suicide in the coming months never knowing that ketamine therapy exists. In any case, KRIYA was again an amazing experience. Dr. Raquel Bennett and her team did a great job of organizing the event and continue to do an amazing job of creating a forum for leaders on the field of ketamine therapy to collaborate and develop the field. I will definitely look forward to KRIYA 2017![/fusion_text]

错误: 内容受保护!